Moreover, inhibition of HAS3 or treatment with the CD44 antibody decreased the expression of Ki67 in U251 or LN229 glioma cells, respectively (Fig. 2D and Supplementary Fig. 2C). The gene discussed is MKI67; the disease is central nervous system cancer.